drugset / Trial / NCT02232308
Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy Subjects
Phase 1
Completed
24 enrolled
Adil Bharucha
National Center for Research Resources (NCRR) · collabNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collab
RandomizedParallel-groupDouble-blindBasic science
Summary
To assess if oral nizatidine or lisinopril alone and in combination will increase heme oxygenase 1 (HO-1) protein concentration and activity compared to placebo in healthy subjects.
Timeline
- Start
- 2014-07
- Primary completion
- 2014-09
- Completion
- 2014-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LISINOPRIL ANHYDROUS | Small molecule | 10 mg | Oral |
| Subject | Nizatidine | Small molecule | 150 mg | Oral |